Rhodes Jennifer J — SEC Form 4 filings

SEC reporting owner CIK 1568249. 5 Form 4 filings on record with FilingPulse; latest filed 2026-03-26.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-02-08 to 2026-03-26. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
ACADIA PHARMACEUTICALS INC (ACAD)EVP, CHIEF LEGAL OFFICER, SEC52 legs · 10,794 sh · $245,02210

Form 4 filings — Rhodes Jennifer J

FiledFormIssuerReported transactionsSource
2026-03-264ACADIA PHARMACEUTICALS INC (ACAD)Option exercise (M): 7,515 @ $0 · Sale (S): 3,844 @ $21.47 · Option exercise (M): 7,515 (derivative) @ $0EDGAR
2026-03-104ACADIA PHARMACEUTICALS INC (ACAD)Grant/award (A): 90,691 (derivative) @ $0 · Grant/award (A): 26,382 (derivative) @ $0EDGAR
2026-02-104ACADIA PHARMACEUTICALS INC (ACAD)Option exercise (M): 12,944 @ $0 · Sale (S): 6,950 @ $23.38 · Option exercise (M): 12,944 (derivative) @ $0EDGAR
2025-03-264ACADIA PHARMACEUTICALS INC (ACAD)Grant/award (A): 102,289 (derivative) @ $0 · Grant/award (A): 30,062 (derivative) @ $0EDGAR
2024-02-084ACADIA PHARMACEUTICALS INC (ACAD)Grant/award (A): 126,589 (derivative) @ $0 · Grant/award (A): 25,889 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1568249 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →